The 2026 probiotic and secretome paper reports no trial results yet because it is a phase 2 trial protocol, not a finished trial. People with acne-prone skin can compare probiotic claims by checking the exact strain, the studied dose, and results from human acne testing. Secretome here means the fluid mix from mesenchymal stem cells, tested as a topical add-on. The plan targets mild-to-moderate acne vulgaris, pairing oral probiotics with that topical mix to improve lesions and support microbiome balance.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the 2026 protocol plans to test
- Why this paper has no outcomes yet
- Why one probiotic result does not cover every product
- How to check an acne probiotic claim
What the 2026 protocol plans to test
Lestari and colleagues published a phase 2 double-blind randomised controlled trial protocol in BMJ Open combining oral probiotics with topical mesenchymal-stem-cell secretome, according to the protocol in BMJ Open. It is designed for mild-to-moderate acne vulgaris alongside standard therapy. The design uses four parallel arms adding probiotic or placebo and secretome or placebo to standard care.
That structure can separate the added effect of probiotics, secretome, or the combination. The paper describes MSC secretomes as containing bioactive factors that stimulate fibroblast migration and angiogenesis. That action is the reason researchers chose secretome as a topical adjunct for acne-prone skin.
Why this paper has no outcomes yet
The paper reports methods, rationale, and analysis plans in future tense because the trial had not yet been conducted. The U.S.
National Library of Medicine PubMed record describes it as a protocol without efficacy results, according to the PubMed record. For readers, that means there are no lesion counts, clearance rates, or microbiome changes to judge yet. The useful information is what will be measured and how bias will be controlled.
Why one probiotic result does not cover every product
Probiotic effects are strain-specific and dose-dependent, so one strain result does not transfer to another product labeled probiotic. The NIH Office of Dietary Supplements states this limit in its probiotics fact sheet.
A capsule, yogurt, cleanser, serum, and moisturizer can carry different strains, doses, and carriers. A gut-symptom study also says little about inflamed lesions, clogged pores, or acne bacteria on skin.
How to check an acne probiotic claim
Shoppers with acne-prone skin should compare the exact strain, studied dose, and relevant human outcome, preferably testing of the actual formulation. Look for human acne data, not only laboratory, animal, or general skin-health data.
The FTC requires health-benefit claims to rest on competent and reliable scientific evidence, generally high-quality human trials matching the marketed use, according to this summary of FTC guidance. If the label lacks strain, dose, and human acne data, treat the claim as marketing rather than evidence.
- Exact strain name, not only genus or "probiotic blend"
- Dose tested and dose sold
- Acne outcome measured in people, such as lesion count or severity score
- Test of the same formula being advertised, ideally a randomised controlled test
You Might Also Like
- The 2026 Oral Probiotic and Topical Secretome Acne Trial Protocol: How People With Acne-Prone Skin Can Compare Probiotic Claims
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: How People With Acne-Prone Skin Can Compare Probiotic Claims
- Probiotics for Acne in a 2026 Systematic Review and Meta-Analysis: How People With Acne-Prone Skin Can Compare Probiotic Claims